Renal denervation (RDN)

On this page you will find a selection of interviews regarding the latest data on renal denervation from TCT Connect 2020, as well as the latest complex sub-analyses from the Onyx ONE Month DAPT program. View a series of short interviews here below!

Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.

Videos included on this page: the Hot Line presentation, an...

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

• Crossover results from the RADIANCE-HTN SOLO trial
• DynamX Bioadaptor, a novel « uncaging » platform
• Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial

Watch this session if you want to learn about patient identification tools in various geographies to identify candidates for renal denervation and how these tools are implemented in clinical practice.

Speakers: Flavio Luciano Ribichini, Tzung-Dau Wang

This interview supported by Medtronic was filmed at PCR e-Course 2020 :...

Watch this session if you want to learn about advancements in the Medtronic renal denervation procedure with the Spyral catheter, to hear up-to-date data behind ablating the renal artery branches, to learn about the science behind RF renal denervation and to understand future procedural advancements.

Speaker: Andrew...

Watch this video if you want to revisit the clinical evidence behind the Medtronic renal denervation programme and to hear the new Pivotal OFF MED result.

Speakers: Konstantinos Tsioufis, Michael Böhm

This interview supported by Medtronic was filmed at PCR e-Course 2020 : see more videos here…

View a selection of abstracts from PCR e-Course 2020 on the topic of Renal denervation:

• Three-year result of the Global Symplicity registry: impact of medication burden

Following the latest trial results showing the safety and efficacy of renal denervation to treat hypertension, this session will provide you with a high-level update on where we stand currently and where we are moving in the near future.

This session was originally presented during PCR e-Course...

Watch this video if you want to learn about long-term data demonstrating the safety and efficacy of renal denervation in various patient subgroups, including those with chronic kidney disease.

Speaker: Pedro De Araujo Goncalves

This interview supported by Medtronic was filmed at PCR e-Course 2020 : see more...

Watch this session to learn about the prevalence and importance of non-adherence to hypertension medication and the role of patient preference, and to learn about renal denervation as an option for both non-adherent and high-risk patients.

Speakers: Joachim Weil, Isabella Sudano

This interview supported by Medtronic was filmed...